关注
Tomoyuki Mizuno
标题
引用次数
引用次数
年份
Therapeutic drug monitoring of tacrolimus-personalized therapy: second consensus report
M Brunet, T Van Gelder, A Åsberg, V Haufroid, DA Hesselink, L Langman, ...
Therapeutic drug monitoring 41 (3), 261-307, 2019
5332019
Cerebrospinal fluid concentration of gefitinib and erlotinib in patients with non-small cell lung cancer
Y Togashi, K Masago, S Masuda, T Mizuno, M Fukudo, Y Ikemi, ...
Cancer chemotherapy and pharmacology 70, 399-405, 2012
2962012
Targeted disruption of the multidrug and toxin extrusion 1 (mate1) gene in mice reduces renal secretion of metformin
M Tsuda, T Terada, T Mizuno, T Katsura, J Shimakura, K Inui
Molecular pharmacology 75 (6), 1280-1286, 2009
2172009
Human ontogeny of drug transporters: review and recommendations of the pediatric transporter working group
KLR Brouwer, LM Aleksunes, B Brandys, GP Giacoia, G Knipp, ...
Clinical Pharmacology & Therapeutics 98 (3), 266-287, 2015
1802015
Personalized therapy for mycophenolate: consensus report by the international association of therapeutic drug monitoring and clinical toxicology
S Bergan, M Brunet, DA Hesselink, KL Johnson-Davis, PK Kunicki, ...
Therapeutic drug monitoring 43 (2), 150-200, 2021
1202021
OCT1 genetic variants influence the pharmacokinetics of morphine in children
T Fukuda, V Chidambaran, T Mizuno, R Venkatasubramanian, ...
Pharmacogenomics 14 (10), 1141-1151, 2013
1132013
Impact of genetic variation in breast cancer resistance protein (BCRP/ABCG2) on sunitinib pharmacokinetics
T Mizuno, M Fukudo, T Terada, T Kamba, E Nakamura, O Ogawa, K Inui, ...
Drug metabolism and pharmacokinetics 27 (6), 631-639, 2012
1132012
Exposure–toxicity relationship of sorafenib in Japanese patients with renal cell carcinoma and hepatocellular carcinoma
M Fukudo, T Ito, T Mizuno, K Shinsako, E Hatano, S Uemoto, T Kamba, ...
Clinical pharmacokinetics 53, 185-196, 2014
1022014
ABCC3 and OCT1 Genotypes Influence Pharmacokinetics of Morphine in Children
R Venkatasubramanian, T Fukuda, J Niu, T Mizuno, V Chidambaran, ...
Pharmacogenomics 15 (10), 1297-1309, 2014
872014
Developmental pharmacokinetics of sirolimus: implications for precision dosing in neonates and infants with complicated vascular anomalies
T Mizuno, T Fukuda, C Emoto, PS Mobberley‐Schuman, AM Hammill, ...
Pediatric blood & cancer 64 (8), e26470, 2017
732017
ABCG2 421C> A polymorphism and high exposure of sunitinib in a patient with renal cell carcinoma
T Mizuno, T Terada, T Kamba, M Fukudo, T Katsura, E Nakamura, ...
Annals of oncology 21 (6), 1382-1383, 2010
702010
A phase II study of continuous oral mTOR inhibitor everolimus for recurrent, radiographic-progressive neurofibromatosis type 1–associated pediatric low-grade glioma: a …
NJ Ullrich, SP Prabhu, AT Reddy, MJ Fisher, R Packer, S Goldman, ...
Neuro-oncology 22 (10), 1527-1535, 2020
652020
Dual imaging of pulmonary delivery and gene expression of dry powder inhalant by fluorescence and bioluminescence
T Mizuno, K Mohri, S Nasu, K Danjo, H Okamoto
Journal of controlled release 134 (2), 149-154, 2009
652009
Robust clinical and laboratory response to hydroxyurea using pharmacokinetically guided dosing for young children with sickle cell anemia
PT McGann, O Niss, M Dong, A Marahatta, TA Howard, T Mizuno, A Lane, ...
American journal of hematology 94 (8), 871-879, 2019
632019
Pharmacokinetics of oral methadone in the treatment of neonatal abstinence syndrome: a pilot study
JR Wiles, B Isemann, T Mizuno, ME Tabangin, LP Ward, H Akinbi, ...
The Journal of pediatrics 167 (6), 1214-1220. e3, 2015
562015
Model-based precision dosing of sirolimus in pediatric patients with vascular anomalies
T Mizuno, C Emoto, T Fukuda, AM Hammill, DM Adams, AA Vinks
European Journal of Pharmaceutical Sciences 109, S124-S131, 2017
542017
Real‐world infliximab pharmacokinetic study informs an electronic health record‐embedded dashboard to guide precision dosing in children with Crohn’s disease
Y Xiong, T Mizuno, R Colman, J Hyams, JD Noe, B Boyle, YT Tsai, ...
Clinical Pharmacology & Therapeutics 109 (6), 1639-1647, 2021
522021
OCT1 Genetic Variants are Associated with Postoperative Morphine-Related Adverse Effects in Children
R Balyan, X Zhang, V Chidambaran, LJ Martin, T Mizuno, T Fukuda, ...
Pharmacogenomics 18 (7), 621-629, 2017
502017
Influence of OCT 1 ontogeny and genetic variation on morphine disposition in critically ill neonates: lessons from PBPK modeling and clinical study
D Hahn, C Emoto, JC Euteneuer, T Mizuno, AA Vinks, T Fukuda
Clinical Pharmacology & Therapeutics 105 (3), 761-768, 2019
482019
Development of a pharmacokinetic‐guided dose individualization strategy for hydroxyurea treatment in children with sickle cell anaemia
M Dong, PT McGann, T Mizuno, RE Ware, AA Vinks
British journal of clinical pharmacology 81 (4), 742-752, 2016
482016
系统目前无法执行此操作,请稍后再试。
文章 1–20